Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009656996> ?p ?o ?g. }
- W3009656996 endingPage "1508" @default.
- W3009656996 startingPage "1499" @default.
- W3009656996 abstract "Abstract Aim To identify people in English primary care with equivalent cardiovascular risk to participants in the sodium–glucose co‐transporter‐2 inhibitor (SGLT‐2i) cardiovascular outcome trials (CVOTs). A secondary objective was to report the usage of SGLT‐2is. Methods Cross‐sectional analysis of people registered with participating practices in the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) network on the 31 December 2016. We derived: (1) proportions of the primary care population eligible for inclusion in each SGLT‐2i CVOT (CANVAS, DECLARE, EMPA‐REG and VERTIS); (2) characteristics of the eligible population compared with trial participants (demographics, disease duration and vascular risk); and (3) differences within the eligible population prescribed SGLT‐2is. Results The proportions of people with type 2 diabetes ( N = 84 394) meeting the inclusion criteria for each CVOT were: DECLARE 27% [95% confidence interval (CI) 26.5–27.1]; CANVAS 17% (16.6–17.1); VERTIS 7% (7.1–7.4); and EMPA‐REG 7% (6.5–6.8). Primary care populations fulfilling inclusion criteria were 5–8 years older than trial cohorts, and <10% with inclusion criteria of each trial were prescribed an SGLT‐2i; a greater proportion were men, and of white ethnicity. Conclusions There was variation in proportions of the primary care type 2 diabetes population fulfilling inclusion criteria of SGLT‐2i CVOTs. The more stringent the inclusion criteria, the lower the proportion identified in a primary care setting. Prescription rates for SGLT‐2is were low in this national database, and there were demographic disparities in prescribing." @default.
- W3009656996 created "2020-03-13" @default.
- W3009656996 creator A5006687609 @default.
- W3009656996 creator A5039010948 @default.
- W3009656996 creator A5052532012 @default.
- W3009656996 creator A5058258192 @default.
- W3009656996 creator A5084241436 @default.
- W3009656996 date "2020-03-28" @default.
- W3009656996 modified "2023-10-13" @default.
- W3009656996 title "Sodium–glucose co‐transporter‐2 inhibitor cardiovascular outcome trials and generalizability to English primary care" @default.
- W3009656996 cites W2135803349 @default.
- W3009656996 cites W2146264128 @default.
- W3009656996 cites W2148219171 @default.
- W3009656996 cites W2342254682 @default.
- W3009656996 cites W2425644022 @default.
- W3009656996 cites W2519510391 @default.
- W3009656996 cites W2554232906 @default.
- W3009656996 cites W2594590765 @default.
- W3009656996 cites W2602058707 @default.
- W3009656996 cites W2626446274 @default.
- W3009656996 cites W2757025413 @default.
- W3009656996 cites W2760309187 @default.
- W3009656996 cites W2779223875 @default.
- W3009656996 cites W2801297032 @default.
- W3009656996 cites W2888686134 @default.
- W3009656996 cites W2894746763 @default.
- W3009656996 cites W2894993577 @default.
- W3009656996 cites W2900413769 @default.
- W3009656996 cites W2903720206 @default.
- W3009656996 cites W2924271721 @default.
- W3009656996 cites W2943242289 @default.
- W3009656996 cites W2948612418 @default.
- W3009656996 doi "https://doi.org/10.1111/dme.14290" @default.
- W3009656996 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7497070" @default.
- W3009656996 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32128875" @default.
- W3009656996 hasPublicationYear "2020" @default.
- W3009656996 type Work @default.
- W3009656996 sameAs 3009656996 @default.
- W3009656996 citedByCount "4" @default.
- W3009656996 countsByYear W30096569962021 @default.
- W3009656996 countsByYear W30096569962022 @default.
- W3009656996 crossrefType "journal-article" @default.
- W3009656996 hasAuthorship W3009656996A5006687609 @default.
- W3009656996 hasAuthorship W3009656996A5039010948 @default.
- W3009656996 hasAuthorship W3009656996A5052532012 @default.
- W3009656996 hasAuthorship W3009656996A5058258192 @default.
- W3009656996 hasAuthorship W3009656996A5084241436 @default.
- W3009656996 hasBestOaLocation W30096569962 @default.
- W3009656996 hasConcept C105795698 @default.
- W3009656996 hasConcept C107993555 @default.
- W3009656996 hasConcept C109359841 @default.
- W3009656996 hasConcept C126322002 @default.
- W3009656996 hasConcept C134018914 @default.
- W3009656996 hasConcept C144024400 @default.
- W3009656996 hasConcept C207103383 @default.
- W3009656996 hasConcept C27158222 @default.
- W3009656996 hasConcept C2777180221 @default.
- W3009656996 hasConcept C2908647359 @default.
- W3009656996 hasConcept C33923547 @default.
- W3009656996 hasConcept C44249647 @default.
- W3009656996 hasConcept C512399662 @default.
- W3009656996 hasConcept C555293320 @default.
- W3009656996 hasConcept C71924100 @default.
- W3009656996 hasConcept C99454951 @default.
- W3009656996 hasConceptScore W3009656996C105795698 @default.
- W3009656996 hasConceptScore W3009656996C107993555 @default.
- W3009656996 hasConceptScore W3009656996C109359841 @default.
- W3009656996 hasConceptScore W3009656996C126322002 @default.
- W3009656996 hasConceptScore W3009656996C134018914 @default.
- W3009656996 hasConceptScore W3009656996C144024400 @default.
- W3009656996 hasConceptScore W3009656996C207103383 @default.
- W3009656996 hasConceptScore W3009656996C27158222 @default.
- W3009656996 hasConceptScore W3009656996C2777180221 @default.
- W3009656996 hasConceptScore W3009656996C2908647359 @default.
- W3009656996 hasConceptScore W3009656996C33923547 @default.
- W3009656996 hasConceptScore W3009656996C44249647 @default.
- W3009656996 hasConceptScore W3009656996C512399662 @default.
- W3009656996 hasConceptScore W3009656996C555293320 @default.
- W3009656996 hasConceptScore W3009656996C71924100 @default.
- W3009656996 hasConceptScore W3009656996C99454951 @default.
- W3009656996 hasFunder F4320307770 @default.
- W3009656996 hasIssue "9" @default.
- W3009656996 hasLocation W30096569961 @default.
- W3009656996 hasLocation W30096569962 @default.
- W3009656996 hasLocation W30096569963 @default.
- W3009656996 hasOpenAccess W3009656996 @default.
- W3009656996 hasPrimaryLocation W30096569961 @default.
- W3009656996 hasRelatedWork W2090763189 @default.
- W3009656996 hasRelatedWork W2154948599 @default.
- W3009656996 hasRelatedWork W2516062397 @default.
- W3009656996 hasRelatedWork W2792916732 @default.
- W3009656996 hasRelatedWork W2793335702 @default.
- W3009656996 hasRelatedWork W2913113213 @default.
- W3009656996 hasRelatedWork W2914671834 @default.
- W3009656996 hasRelatedWork W3114266572 @default.
- W3009656996 hasRelatedWork W4210646467 @default.
- W3009656996 hasRelatedWork W4254083861 @default.
- W3009656996 hasVolume "37" @default.